LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2017

Feb 13, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2017-02-09

Reporting Person: TYLE PRAVEEN (EVP, R&D)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-09	Stock Option (Right to Buy)	$14.44	A	47860	Acquired	2027-02-09	Common Stock (47860)	Direct
2017-02-09	Restricted Stock Units (Phantom Stock)	$	A	11960	Acquired		Common Stock (11960)	Direct

Footnotes

F1: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/9/2018) and vests 1/48th per month for each month of service thereafter

F2: Each restricted stock unit represents a contingent right to receive one share of common stock.

F3: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.